Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
cannabinoids
Biotech
Novo Nordisk bets $1B on biotech buyout to grow obesity pipeline
Novo Nordisk inked a deal worth up to $1.1 billion to buy a biotech that is dusting off an old approach to triggering weight loss.
Nick Paul Taylor
Aug 10, 2023 6:30am
Fortrea inks deal with Incannex for sleep apnea drug trial
Jul 27, 2023 9:28am
Cannabinoid-focused drugmaker InMed backs away from H&W sector
Sep 9, 2022 7:45am
Anebulo drug reduces cannabinoid intoxication in phase 2 study
Jul 5, 2022 12:39pm
Cannabidiol shows promise against superbugs
Jun 24, 2019 12:11pm
Corbus nets over 600 cannabinoid compounds, to test 1-2 per year
Sep 20, 2018 9:32am